Skip to main content

CITIGROUP INC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 831001 NEW YORK, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$32,224
+$26,433 QoQ
Shares Held
74,940
+935.1% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Derivatives in HRTX

reported options exposure · as of Mar 31, 2020
CallValue
$21,132
CallShares
1,800
PutValue
$98,616
PutShares
8,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. HRTX ranks #308 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,224 74,940
2026-03-31 $5,791 7,240
2025-12-31 $4,521 3,478
2025-09-30 $3,120,425 2,476,529
2025-06-30 $107,541 51,953
2025-03-31 $180,051 81,842
2024-12-31 $139,250 91,014
2024-09-30 $171,105 85,983
2024-06-30 $176,679 50,480
2024-03-31 $48,371 17,463
2023-12-31 $31,347 18,440
2023-09-30 $215 210
2023-06-30 $35,779 30,845
2023-03-31 $15,753 10,433
2022-12-31 $27,487 10,995
2022-09-30 $2,350,927 557,092
2022-06-30 $2,130,206 763,515
2022-03-31 $861,472 150,607
2021-12-31 $4,023,444 440,684
2021-09-30 $2,098,243 196,281
2021-06-30 $4,613,737 297,277
2021-03-31 $4,007,743 247,239
2020-12-31 $447,194 21,124
2020-09-30 $89,067 6,010
2020-06-30 $895,926 60,906
2020-03-31 $21,132 1,800
2020-03-31 $98,616 8,400
2020-03-31 $732,540 62,397